Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity
Stage Focus
Buyout, Growth
Geographical Focus
United States, United Kingdom, Continental Europe
Industries Focus
- Education
- Business & Financial Services
- Leisure
- Healthcare & Life Sciences
- TICC
- Niche Industrials
Investor Details Founded: 2015
Limerston Capital is a London-based private equity firm that manages over £500 million in assets, focusing on UK lower mid-market companies with enterprise values between £50 million and £200 million. The firm pursues control investments, aiming to create value through operational transformation and buy-and-build strategies. By partnering with management teams, Limerston Capital seeks to unlock potential and accelerate growth, transforming businesses into industry leaders and delivering strong returns for investors.
The firm's investment strategy emphasizes a concentrated portfolio, allowing dedicated resources to each company. Limerston Capital targets sectors such as Healthcare & Life Sciences, Business & Financial Services, TICC, Leisure, Niche Industrials, and Education. The firm employs a buy-and-build approach, executing 31 follow-on acquisitions to rapidly scale and consolidate market share.
Limerston Capital's operational support includes in-house sector-specialist operating partners who work alongside the investment team and company management prior to deal completion, enabling more rapid growth post-acquisition. The firm has a proven track record of delivering superior returns through its buy-and-build strategy in the UK, with opportunistic expansions to the US and Continental Europe.
Requirements
- Businesses with EBITDA between £5 million and £15 million
- Potential for operational improvements
- Opportunities for strategic repositioning via consolidation
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Analytical Expert Labs
- Arch Sciences Group
- Astoriom
- Concept Life Sciences
- Cormica Group
Mentioned In
-
$24.95
-
$19.95
-
$19.95
-
$39.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of Limerston Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim